Clinical Trials Directory

Trials / Completed

CompletedNCT01123512

The Kiva® System as a Vertebral Augmentation Treatment

The Kiva® System as a Vertebral Augmentation Treatment - A Safety and Effectiveness Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
300 (actual)
Sponsor
Benvenue Medical, Inc. · Industry
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the safety and effectiveness of the Kiva VCF Treatment system in comparison to balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures of the thoracic or lumbar spine.

Conditions

Interventions

TypeNameDescription
DEVICEVertebral augmentationVertebral augmentation for one or two osteoporotic vertebral compression fractures

Timeline

Start date
2010-07-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2010-05-14
Last updated
2014-10-09
Results posted
2014-08-21

Locations

21 sites across 5 countries: United States, Belgium, Canada, France, Germany

Source: ClinicalTrials.gov record NCT01123512. Inclusion in this directory is not an endorsement.

The Kiva® System as a Vertebral Augmentation Treatment (NCT01123512) · Clinical Trials Directory